Yale Medicine School: Learning Which Genetic Changes Predict Greatest Risk of Cancer Death
April 12, 2022
April 12, 2022
NEW HAVEN, Connecticut, April 12 (TNSJou) -- Yale School of Medicine issued the following news:
In the face of cancer, oncologists face a dual epidemic of overtreatment and undertreatment. Treating the disease often involves harsh chemotherapies and other interventions with extensive side effects. As a result, clinicians might delay treating a growth that looks harmless until it becomes life threatening and too late to treat. Or, they might overly treat a less aggressive cancer with . . .
In the face of cancer, oncologists face a dual epidemic of overtreatment and undertreatment. Treating the disease often involves harsh chemotherapies and other interventions with extensive side effects. As a result, clinicians might delay treating a growth that looks harmless until it becomes life threatening and too late to treat. Or, they might overly treat a less aggressive cancer with . . .